Enhancing immune effects of a DNA vaccine against kidney cancer using CD40L as an adjuvant. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 55, p. e18173, 2019. DOI: 10.1590/s2175-97902019000218173. Disponível em: https://revistas.usp.br/bjps/article/view/164799.. Acesso em: 1 may. 2024.